Comparison of real-world healthcare resource utilization among advanced therapy-naïve and advanced therapy-experienced patients with ulcerative colitis initiated on ustekinumab or vedolizumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of real-world healthcare resource utilization among advanced therapy-naïve and advanced therapy-experienced patients with ulcerative colitis initiated on ustekinumab or vedolizumab

Published:2024-08-13 Issue:9 Volume:40 Page:1555-1562
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Zhdanava Maryia¹,Kachroo Sumesh²,Boonmak Porpong¹,Burbage Sabree²,Shah Aditi¹,Korsiak Jill¹,Lefebvre Patrick¹,Kerner Caroline²,Pilon Dominic¹

Affiliation:

1. Analysis Group Inc., Montréal, Canada

2. Janssen Scientific Affairs, LLC, a Johnson & Johnson Company, Horsham, PA, USA

Funder

Janssen Scientific Affairs, LLC, a Johnson & Johnson Company

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2024.2388839

Reference28 articles.

1. Ulcerative colitis

2. Prevalence of Inflammatory Bowel Disease in Pediatric and Adult Populations: Recent Estimates From Large National Databases in the United States, 2007–2016

3. Crohn’s & Colitis Foundation of America. 2014. [cited 2018 May 15]. Available from: http://www.crohnscolitisfoundation.org/assets/pdfs/updatedibdfactbook.pdf.

4. Ulcerative colitis

5. Quality of life in patients with moderate to severe ulcerative colitis and the impact of treatment: A narrative review

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP